4.7 Review

Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Germline Alterations in Patients With IBD-associated Colorectal Cancer

Giuseppe Biscaglia et al.

Summary: This study investigated germline alterations in patients with inflammatory bowel disease (IBD)-associated colorectal cancer (CRC). The results showed that a significant proportion of IBD patients with CRC had pathogenic variants in cancer-related genes. Those with pathogenic variants had earlier onset of high-grade dysplasia or CRC compared to patients with benign or unidentified variants. Screening for these genes could help identify IBD patients who require more intensive surveillance for early detection of dysplastic changes.

INFLAMMATORY BOWEL DISEASES (2022)

Article Gastroenterology & Hepatology

A Nucleotide Analog Prevents Colitis-Associated Cancer via Beta-Catenin Independently of Inflammation and Autophagy

Yong Hua Sheng et al.

Summary: The study demonstrates that thioguanine nucleotide can inhibit Wnt/beta-catenin signaling via Rac1 to prevent carcinogenesis in colonic epithelial cells, independently of inflammation and autophagy.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer

Xiaoyan Fan et al.

Summary: The gut microbiota dysbiosis in CRC may drive the development and progression of colorectal cancer. Evaluating changes in the gut microbiota during CRC development and progression offers a new strategy for the diagnosis and treatment of this disease.

DIGESTION (2021)

Article Gastroenterology & Hepatology

Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy

Motasem Alkhayyat et al.

Summary: The use of biologic agents can reduce the risk of colorectal cancer in patients with inflammatory bowel disease, especially for those treated with anti-TNF agents. Further prospective studies are needed to evaluate the chemoprotective effect of anti-tumor necrosis factor drugs in IBD patients through inflammation control and mucosal healing.

INFLAMMATORY BOWEL DISEASES (2021)

Review Gastroenterology & Hepatology

Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis

Anouk M. Wijnands et al.

Summary: A systematic review and meta-analysis identified 13 risk factors and 5 protective factors for advanced colorectal neoplasia in IBD patients. These findings could contribute to an improved surveillance based on CRC risk stratification in IBD.

GASTROENTEROLOGY (2021)

Article Immunology

Wnt-β-catenin activation epigenetically reprograms Treg cells in inflammatory bowel disease and dysplastic progression

Jasmin Quandt et al.

Summary: The study found that in individuals with inflammatory bowel disease, there is a progressive expansion of ROR gamma t(+) T-reg cells, and activating Wnt-beta-catenin signaling can induce the expression of pro-inflammatory cytokines and the ROR gamma t(+) T-reg phenotype in these cells. TCF-1 and Foxp3 together limit the expression of pro-inflammatory genes in T-reg cells.

NATURE IMMUNOLOGY (2021)

Article Cell Biology

Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer

Luisa Klemke et al.

Summary: The study demonstrates that MIF stabilization in CRC is tumor-specific, and Mif deletion reduces CRC tumor growth, suggesting a dual role for MIF in CRC tumor progression, switching from a proinflammatory cytokine to an angiogenesis promoting factor. Additionally, Mif-deficient colonic tumor organoids show growth defects and decreased susceptibility to HSP90 inhibitor treatment, supporting MIF as a potential and selective therapeutic target in CRC.

CELL DEATH & DISEASE (2021)

Article Immunology

MAPKAP Kinase-2 Drives Expression of Angiogenic Factors by Tumor-Associated Macrophages in a Model of Inflammation-Induced Colon Cancer

Lucia Suarez-Lopez et al.

Summary: The activity of MK2 in macrophages is essential for tumor angiogenesis during inflammation-induced cancer progression, by regulating various pro-angiogenesis factors, including CXCL-12/SDF-1 secreted by tumor associated-macrophages.

FRONTIERS IN IMMUNOLOGY (2021)

Article Gastroenterology & Hepatology

Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer

Kristiina Rajamaki et al.

Summary: By comprehensively characterizing IBD-associated tumorigenesis using multiple high-throughput approaches, distinct mechanisms of WNT pathway dysregulation were identified in IBD-CRC, which skew the tumors towards a mesenchymal subtype. Additionally, epigenetic modifications and noncoding mutations in specific genes were found in IBD-CRC, highlighting further differences compared to sCRC.

GASTROENTEROLOGY (2021)

Review Biochemistry & Molecular Biology

The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer

Marco Bocchetti et al.

Summary: This review summarizes the major dysregulated miRNAs in CAC and their potential applications in early diagnosis, therapy prediction, and precision treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer

Eva Pastille et al.

Summary: In this study, the research team found that blocking TLR4 signaling during the inflammatory phases of CAC can significantly reduce the development and progression of colonic tumors, as well as decrease inflammation levels, providing a novel approach to impede CAC development.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Colibactin-Producing Escherichia coli Induce the Formation of Invasive Carcinomas in a Chronic Inflammation-Associated Mouse Model

Laurene Salesse et al.

Summary: Colorectal cancer patients show changes in intestinal flora with an increase in harmful bacteria such as Escherichia coli, which can cause DNA damage. Autophagy is a crucial cell defense mechanism that inhibits tumorigenesis. Targeting autophagy may be a promising strategy to counteract the protumoral effects of bacteria like E. coli producing colibactin.

CANCERS (2021)

Review Immunology

The inflammatory pathogenesis of colorectal cancer

Mark Schmitt et al.

Summary: The research on colorectal cancer indicates the importance of an inflammatory microenvironment for tumorigenesis, which influences the activation of immune cells and stromal cells, as well as the role of intestinal microbiome in tumor development. Chronic inflammation can initiate tumorigenesis, and tumor-elicited and therapy-induced inflammation are also implicated in promoting colorectal cancer.

NATURE REVIEWS IMMUNOLOGY (2021)

Article Gastroenterology & Hepatology

Evolutionary history of human colitis-associated colorectal cancer

Ann-Marie Baker et al.

Article Gastroenterology & Hepatology

Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation

Hari K. Somineni et al.

GASTROENTEROLOGY (2019)

Article Microbiology

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease

Alessandra Lo Presti et al.

FRONTIERS IN MICROBIOLOGY (2019)

Article Gastroenterology & Hepatology

Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis

Manisha Bajpai et al.

DIGESTIVE DISEASES AND SCIENCES (2019)

Article Immunology

Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification

Matthew T. Sorbara et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2019)

Review Biochemistry & Molecular Biology

Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer

Rei Mizuno et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Oncology

Colorectal carcinoma in the course of inflammatory bowel diseases

Andrzej Hnatyszyn et al.

HEREDITARY CANCER IN CLINICAL PRACTICE (2019)

Article Biochemistry & Molecular Biology

Short-chain fatty acids administration is protective in colitis-associated colorectal cancer development

Yun Tian et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)

Review Oncology

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Daniel E. Johnson et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Immunology

Toll-like Receptors and inflammatory Bowel Disease

Yue Lu et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

Streptococcus gallolyticus conspires myeloid cells to promote tumorigenesis of inflammatory bowel disease

Yucheng Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Gastroenterology & Hepatology

Mucosa-associated microbiota dysbiosis in colitis associated cancer

Mathias L. Richard et al.

GUT MICROBES (2018)

Article Gastroenterology & Hepatology

The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease

F. Carrat et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Article Biochemistry & Molecular Biology

Inflammation-associated DNA methylation patterns in epithelium of ulcerative colitis

Alan Barnicle et al.

EPIGENETICS (2017)

Article Multidisciplinary Sciences

Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients

Maria Laura Santoru et al.

SCIENTIFIC REPORTS (2017)

Article Oncology

Inflammation and Colorectal Cancer

Apple G. Long et al.

CURRENT COLORECTAL CANCER REPORTS (2017)

Article Gastroenterology & Hepatology

Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview

Chang-Ho Ryan Choi et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Review Gastroenterology & Hepatology

Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies

Sahil Gambhir et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Review Gastroenterology & Hepatology

Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis

C. Castano-Milla et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)

Article Multidisciplinary Sciences

Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer

Xujun Liang et al.

SCIENTIFIC REPORTS (2014)

Article Gastroenterology & Hepatology

The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment

Guillaume Dalmasso et al.

GUT MICROBES (2014)

Article Medicine, Research & Experimental

NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer

Aurelie Couturier-Maillard et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Article Multidisciplinary Sciences

TLR4 Activates the β-catenin Pathway to Cause Intestinal Neoplasia

Rebeca Santaolalla et al.

PLOS ONE (2013)

Article Gastroenterology & Hepatology

Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort Studies

Tine Jess et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Microbiology

Microbial Dysbiosis in Pediatric Patients with Crohn's Disease

Nadeem O. Kaakoush et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2012)

Article Gastroenterology & Hepatology

5-Aminosalicylate Is Not Chemoprophylactic for Colorectal Cancer in IBD: A Population Based Study

Charles N. Bernstein et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)

Article Rheumatology

Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage

Sergei I. Grivennikov et al.

ANNALS OF THE RHEUMATIC DISEASES (2011)

Article Gastroenterology & Hepatology

Intestinal Inflammation and Cancer

Thomas A. Ullman et al.

GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Methylation Status of Genes in Non-Neoplastic Mucosa From Patients With Ulcerative Colitis-Associated Colorectal Cancer

Megan M. Garrity-Park et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Article Oncology

Prevention of Colitis-Associated Carcinogenesis with Infliximab

Yoon Jae Kim et al.

CANCER PREVENTION RESEARCH (2010)

Article Gastroenterology & Hepatology

Signaling pathway via TNF-α/NF-κB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis

Michio Onizawa et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)

Review Microbiology

Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses

Trine H. Mogensen

CLINICAL MICROBIOLOGY REVIEWS (2009)

Review Pharmacology & Pharmacy

Overview of the Role of Macrophage Migration Inhibitory Factor (MIF) in Inflammatory Bowel Disease

Jun Nishihira et al.

CURRENT PHARMACEUTICAL DESIGN (2009)

Article Biochemistry & Molecular Biology

Role for sphingosine kinase 1 in colon carcinogenesis

Toshihiko Kawamori et al.

FASEB JOURNAL (2009)

Article Multidisciplinary Sciences

Clonal expansions in ulcerative colitis identify patients with neoplasia

Jesse J. Salk et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Medicine, Research & Experimental

Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis

Boryana K. Popivanova et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Article Gastroenterology & Hepatology

Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia

Mashaal Dhir et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2008)

Editorial Material Medicine, General & Internal

Tumor necrosis factor α and colitis-associated colon cancer

Joanne A. P. Wilson

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Gastroenterology & Hepatology

5-aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease

Jonathan P. Terdiman et al.

INFLAMMATORY BOWEL DISEASES (2007)

Article Gastroenterology & Hepatology

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis

M Rutter et al.

GASTROENTEROLOGY (2004)

Article Gastroenterology & Hepatology

Mucosal flora in inflammatory bowel disease

A Swidsinski et al.

GASTROENTEROLOGY (2002)

Review Gastroenterology & Hepatology

The risk of colorectal cancer in ulcerative colitis: a meta-analysis

JA Eaden et al.